| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |